184 related articles for article (PubMed ID: 20508670)
21. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread.
Cheshenko N; Herold BC
J Gen Virol; 2002 Sep; 83(Pt 9):2247-2255. PubMed ID: 12185280
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
24. HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.
Menotti L; Avitabile E; Gatta V; Malatesta P; Petrovic B; Campadelli-Fiume G
Viruses; 2018 Jun; 10(7):. PubMed ID: 29966356
[TBL] [Abstract][Full Text] [Related]
25. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.
Tal-Singer R; Peng C; Ponce De Leon M; Abrams WR; Banfield BW; Tufaro F; Cohen GH; Eisenberg RJ
J Virol; 1995 Jul; 69(7):4471-83. PubMed ID: 7769707
[TBL] [Abstract][Full Text] [Related]
26. Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
Uchida H; Marzulli M; Nakano K; Goins WF; Chan J; Hong CS; Mazzacurati L; Yoo JY; Haseley A; Nakashima H; Baek H; Kwon H; Kumagai I; Kuroki M; Kaur B; Chiocca EA; Grandi P; Cohen JB; Glorioso JC
Mol Ther; 2013 Mar; 21(3):561-9. PubMed ID: 23070115
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate.
Trybala E; Svennerholm B; Bergström T; Olofsson S; Jeansson S; Goodman JL
J Virol; 1993 Mar; 67(3):1278-85. PubMed ID: 8382294
[TBL] [Abstract][Full Text] [Related]
28. Folate-conjugated herpes simplex virus for retargeting to tumor cells.
Ye ZQ; Zou CL; Chen HB; Lv QY; Wu RQ; Gu DN
J Gene Med; 2020 Jul; 22(7):e3177. PubMed ID: 32096291
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
Trybala E; Olofsson S; Mårdberg K; Svennerholm B; Umemoto K; Glorioso JC; Bergström T
Antiviral Res; 2004 Jun; 62(3):125-34. PubMed ID: 15130536
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.
Trybala E; Liljeqvist JA; Svennerholm B; Bergström T
J Virol; 2000 Oct; 74(19):9106-14. PubMed ID: 10982357
[TBL] [Abstract][Full Text] [Related]
31. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
J Virol; 2017 May; 91(10):. PubMed ID: 28250120
[TBL] [Abstract][Full Text] [Related]
32. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus type 1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan sulfate.
Lee WC; Fuller AO
J Virol; 1993 Sep; 67(9):5088-97. PubMed ID: 8394437
[TBL] [Abstract][Full Text] [Related]
34. Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein.
Wang X; Kong L; Zhang GR; Sun M; Geller AI
Brain Res Mol Brain Res; 2005 Sep; 139(1):88-102. PubMed ID: 15993510
[TBL] [Abstract][Full Text] [Related]
35. Tumour-specific triple-regulated oncolytic herpes virus to target glioma.
Delwar ZM; Liu G; Kuo Y; Lee C; Bu L; Rennie PS; Jia WW
Oncotarget; 2016 May; 7(19):28658-69. PubMed ID: 27070093
[TBL] [Abstract][Full Text] [Related]
36. Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.
Trybala E; Roth A; Johansson M; Liljeqvist JA; Rekabdar E; Larm O; Bergström T
Virology; 2002 Oct; 302(2):413-9. PubMed ID: 12441085
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide.
Aghi M; Rabkin SD; Martuza RL
Cancer Res; 2007 Jan; 67(2):440-4. PubMed ID: 17234749
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
Andreansky S; Soroceanu L; Flotte ER; Chou J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
Cancer Res; 1997 Apr; 57(8):1502-9. PubMed ID: 9108452
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.
Kamiyama H; Zhou G; Roizman B
Gene Ther; 2006 Apr; 13(7):621-9. PubMed ID: 16292350
[TBL] [Abstract][Full Text] [Related]
40. A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.
Dick JW; Rosenthal KS
Arch Virol; 1995; 140(12):2163-81. PubMed ID: 8572939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
